UNION CITY, Calif.,
Oct. 25, 2011 /PRNewswire/ -- Abaxis,
Inc. (NasdaqGS: ABAX), a medical products company manufacturing
point-of-care blood analysis systems, has scheduled a conference
call to discuss its financial results for the second quarter of
fiscal year 2012, ended September 30,
2011. The call will be at 4:15 p.m.
ET on Tuesday, October 25,
2011. The Company will report financial results for
the second quarter of fiscal year 2012 after the market closes on
Tuesday, October 25, 2011.
Participants can dial (877) 317-6789 or (412) 317-6789 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
Company's website at www.abaxis.com. A replay of the call is
available by visiting www.abaxis.com for the next 30 days or by
calling (877) 344-7529 or (412) 317-0088, confirmation code
10005496, through November 1,
2011.
About Abaxis
Abaxis develops, manufactures, markets and sells portable blood
analysis systems for use in any veterinary or human patient-care
setting to provide clinicians with rapid blood constituent
measurements. The system consists of a compact, 5.1 kilogram
(11.2 pounds), portable analyzer and a series of single-use plastic
discs, called reagent discs that contain all the chemicals required
to perform a panel of up to 13 tests on veterinary patients and 14
tests on human patients. The system can be operated with
minimal training and performs multiple routine tests on whole
blood, serum or plasma samples. The system provides test
results in less than 12 minutes with the precision and accuracy
equivalent to a clinical laboratory analyzer. The veterinary
business also provides to the animal health and research market a
line of hematology instruments for point-of-care complete blood
counts (CBC), a specialty instrument to screen for and detect
clotting disorders and to measure equine fibrinogen levels, a
handheld instrument for the rapid assessment of certain critical
care tests and rapid point-of-care tests for Heartworm infections
in dogs, Parvovirus and Giardia. Abaxis, through its AVRL
Division, provides routine laboratory testing as well as specialty
testing for veterinarians' nationwide. This state-of-the-art
commercial laboratory will be the hub of the Abaxis Veterinary
Reference Laboratories (AVRL).
Contact:
|
Clint Severson
|
Lytham Partners,
LLC
|
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz &
Robert Blum
|
|
|
Abaxis, Inc.
|
602-889-9700
|
|
|
510-675-6500
|
|
|
|
|
|
SOURCE Abaxis, Inc.